| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 02/12/2009 | US20090042181 Expresion vector comprising hepatitis C viral sequences for use in development and evaluation of antiviral drugs; drug screening |
| 02/12/2009 | US20090042180 System for sampling and tracking plant material |
| 02/12/2009 | US20090042179 Fluorescence Reflection Imaging Device with Two Wavelengths |
| 02/12/2009 | US20090041891 Gene Encoding Transcriptional Inducer for Maltase Gene and Maltose Transporter Gene and use Thereof |
| 02/12/2009 | US20090041889 Gene Encoding Protein With Vicinal Diketone or Diacetyl-Reducing Activity and Use Thereof |
| 02/12/2009 | US20090041862 Detecting disease association with aberrant glycogen synthase kinase 3beta expression |
| 02/12/2009 | US20090041861 Estrogen receptor alleles that are predictive of increased susceptibility to bone fracture |
| 02/12/2009 | US20090041836 Glycolipopeptide and uses thereof |
| 02/12/2009 | US20090041825 Cell culture well-plates having inverted colloidal crystal scaffolds |
| 02/12/2009 | US20090041808 Detection/Measurement Of Malaria Infection Disease Utilizing Natural Immunity By Hemozoin Induction, Screening Of Preventative Or Therapeutic Medicine For Malaria Infection Disease, And Regulation Of Natural Immunity Induction |
| 02/12/2009 | US20090041782 Novel serotype streptococcus mutans and utilization of the same |
| 02/12/2009 | US20090041777 G-protein specific immunoglobulin targeting and treatment of viral disorders; Drug screening |
| 02/12/2009 | US20090041774 Haemophilus influenzae type IV pili |
| 02/12/2009 | US20090041773 Methods for diagnosis and treatment of proliferative disorders mediated by cd40 signaling |
| 02/12/2009 | US20090041772 Soluble Forms of Hendra and Nipah Virus G Glycoprotein |
| 02/12/2009 | US20090041766 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 02/12/2009 | US20090041760 Retroviral immunotherapy |
| 02/12/2009 | US20090041757 Bone morphogenetic protein antagonist and uses thereof |
| 02/12/2009 | US20090041754 Method for identifying target protein of drug and method for screening therapeutic agent for diabetes using the target protein |
| 02/12/2009 | US20090041750 Treatment of spongiform encephalopathy by increased hydrogen peroxide degradation |
| 02/12/2009 | US20090041749 Compositions and methods for the diagnosis and treatment of tumor |
| 02/12/2009 | US20090041719 Method for screening therapeutic agent for glomerular disorder |
| 02/12/2009 | US20090041669 Light-Emitting Biomarker |
| 02/12/2009 | US20090041668 Non-invasive localization of a light-emitting conjugate in a mammal |
| 02/12/2009 | US20090041661 Measurement of biosynthesis and breakdown rates of biological molecules that are inaccessible or not easily accessible to direct sampling, non-invasively, by label incorporation into metabolic derivatives and catabolitic products |
| 02/12/2009 | US20090041623 Fluid analyzing apparatus |
| 02/12/2009 | US20090039274 Surface contamination analyzer for semiconductor wafers, method used therein and process for fabricating semiconductor device |
| 02/12/2009 | DE202008010099U1 Multifunktionales und mobiles Hygiene- und Diagnoseset im Taschenformat zur kombinierten Anwendung von Diagnostika, Therapeutika und Hygieneartikeln Multifunctional and mobile health and diagnostic kit, pocket-sized for the combined application of diagnostics, therapeutics and hygiene products |
| 02/12/2009 | DE102007036866A1 System, umfassend Wirkstoffe umfassende Partikel und Bakteriophagen System comprising active ingredients comprehensive particles and bacteriophage |
| 02/12/2009 | DE102005045560B4 Verfahren zur quantitativen Bestimmung der Kopienzahl einer vorbestimmten Sequenz in einer Zelle A method for quantitative determination of the copy number of a predetermined sequence in a cell |
| 02/12/2009 | CA2718472A1 Use of phosphatases to treat neuroblastomas and medulloblastomas |
| 02/12/2009 | CA2702845A1 Method for generation and use of isotopic patterns in mass spectral data of simple organisms |
| 02/12/2009 | CA2699433A1 Use of polynucleotides for detecting gene activities for distinguishing between local and systemic infection |
| 02/12/2009 | CA2695897A1 Method of identifying individuals at risk of thiopurine drug resistance and intolerance |
| 02/12/2009 | CA2695610A1 Methods to identify soybean aphid resistant quantitative trait loci in soybean and compositions thereof |
| 02/12/2009 | CA2695514A1 Ultraconserved regions encoding ncrnas |
| 02/12/2009 | CA2695505A1 Znf206: a novel regulator of embryonic stem cell self-renewal and pluripotency |
| 02/12/2009 | CA2695369A1 In-situ hybridization to detect rna and dna markers |
| 02/12/2009 | CA2695244A1 Caspase imaging probes |
| 02/12/2009 | CA2695191A1 I-plastin assay method for the in vitro diagnosis of colorectal cancer |
| 02/12/2009 | CA2694832A1 Novel single nucleotide polymorphisms and combinations of novel and known polymorphisms for determining the allele-specific expression of the igf2 gene |
| 02/12/2009 | CA2694619A1 Analysis of nucleic acids by digital pcr |
| 02/12/2009 | CA2694219A1 Regulators of protein misfolding and neuroprotection and methods of use |
| 02/12/2009 | CA2693658A1 Apolipoprotein aii assay method for the in vitro diagnosis of colorectal cancer |
| 02/12/2009 | CA2693648A1 Ezrin assay method for the in vitro diagnosis of colorectal cancer |
| 02/12/2009 | CA2693384A1 Suppression of amplification using an oligonucleotide and a polymerase significantly lacking 5'-3' exonuclease activity |
| 02/12/2009 | CA2693237A1 Composition and method for treatment of reperfusion injury and tissue damage |
| 02/12/2009 | CA2693098A1 Method for the assay of liver fatty acid-binding protein, ace and ca19-9 for the in vitro diagnosis of colorectal cancer |
| 02/12/2009 | CA2693096A1 Apolipoprotein ai assay method for the in vitro diagnosis of colorecta cancer |
| 02/12/2009 | CA2693090A1 Aminoacylase 1 assay method for the in vitro diagnosis of colorectal cancer |
| 02/11/2009 | EP2023127A1 Organism specimen imaging method and organism specimen imaging device |
| 02/11/2009 | EP2022863A1 Application of biosensor chips |
| 02/11/2009 | EP2022862A1 Method of diagnosing of exposure to toxic agents by measuring distinct pattern in the levels of expression of specific genes |
| 02/11/2009 | EP2022861A1 Method for detecting disease-related marker using gastric mucosal lavage fluid |
| 02/11/2009 | EP2022860A1 An oligonucleotide probe and a process for detecting or discriminating microorganisms in a sample |
| 02/11/2009 | EP2022859A1 Method and device for determining the concentration of an analyte using measurement of fluorescence |
| 02/11/2009 | EP2022858A1 Two-Step Gram Staining Method |
| 02/11/2009 | EP2022857A2 Sensing member for detecting total cholesterol of blood sample |
| 02/11/2009 | EP2022856A2 Improvements in or relating to binding proteins for recognition of DNA |
| 02/11/2009 | EP2022850A1 Flavin adenine dinucleotide-binding glucose dehydrogenase |
| 02/11/2009 | EP2022846A1 Method for isolation of stem cell |
| 02/11/2009 | EP2022845A1 Apparatus for judging cell detachment, method of judging cell detachment and cell culture apparatus |
| 02/11/2009 | EP2022559A2 Nucleic acid library or protein or peptide library |
| 02/11/2009 | EP2021806A1 Method and means for the enzymatic determination of ethanol |
| 02/11/2009 | EP2021804A1 Diagnostic assay for spongiform encephalopathies |
| 02/11/2009 | EP2021800A1 Determination of changes in concentration |
| 02/11/2009 | EP2021794A1 Use of protein s100a 12 as a marker for colorectal cancer |
| 02/11/2009 | EP2021789A2 Apparatus and method for performing mass spectroscopy |
| 02/11/2009 | EP2021778A1 Nonseparation assay methods |
| 02/11/2009 | EP2021534A1 Assessment and reduction of risk of graft-versus-host disease |
| 02/11/2009 | EP2021515A1 Methylated promoters as biomarkers of colon cancer |
| 02/11/2009 | EP2021514A2 Detection of nucleic acid targets using chemically reactive oligonucleotide probes |
| 02/11/2009 | EP2021513A2 Compositions and methods to detect enterococci nucleic acid |
| 02/11/2009 | EP2021512A2 Systems and methods for developing diagnostic tests based on biomarker information from legacy clinical sample sets |
| 02/11/2009 | EP2021511A2 Methods for diagnosing and predicting non-alcoholic steatohepatitis (nash) |
| 02/11/2009 | EP2021510A2 Composition and methods for the detection of cripto-3 |
| 02/11/2009 | EP2021509A2 Procedure and methods for detecting alzheimer's disease |
| 02/11/2009 | EP2021508A1 Ambient temperature stable kits for molecular diagnostics |
| 02/11/2009 | EP2021506A2 Use of products of pcr amplification carrying elements of secondary structure to improve pcr-based nucleic acid detection |
| 02/11/2009 | EP2021505A2 Men1 is a marker and therapeutic target for breast and prostate cancer |
| 02/11/2009 | EP2021504A2 Spsis detection microarray |
| 02/11/2009 | EP2021503A1 Isothermal methods for creating clonal single molecule arrays |
| 02/11/2009 | EP2021502A1 Novel genes and markers in type 2 diabetes and obesity |
| 02/11/2009 | EP2021501A1 Real-time multiplex detection of three bacterial species responsible for sexually-transmitted diseases |
| 02/11/2009 | EP2021500A2 Selective modulation of receptor signalling |
| 02/11/2009 | EP2021499A2 Functional arrays for high throughput characterization of gene expression regulatory elements |
| 02/11/2009 | EP2021498A1 Identification of tumor suppressor genes in an acute myeloid leukaemia model |
| 02/11/2009 | EP2021497A1 Modified microbial nucleic acid for use in detection and analysis of microorganisms |
| 02/11/2009 | EP2021496A2 Compositions and methods for detecting and treating hiv infection |
| 02/11/2009 | EP2021493A2 Methods and reagents for detecting susceptibility to graft versus host disease or transplant related mortality |
| 02/11/2009 | EP2021492A2 Quantification of enzyme activity by mass spectrometry |
| 02/11/2009 | EP2021491A2 Detecting tumor biomarker in oral cancer |
| 02/11/2009 | EP2021467A1 Chimeric pcsk9 proteins, cells comprising same, and assays using same |
| 02/11/2009 | EP2021465A2 Thermostable dna polymerase of the archaeal ampullavirus abv and its applications |
| 02/11/2009 | EP2021415A2 Dye compounds and the use of their labelled conjugates |
| 02/11/2009 | EP2021186A2 Diagnostic test media and methods for the manufacture thereof |
| 02/11/2009 | EP2021023A2 Myxoma virus mutants for cancer treatment |
| 02/11/2009 | EP2021018A2 Rapid detection of mycobacterium tuberculosis and antimicrobial drug resistance |
| 02/11/2009 | EP2021009A2 Methods to improve creatine kinase metabolism and contractile function in cardiac muscle for the treatment of heart failure |
| 02/11/2009 | EP2020909A2 Abnormal output detection system for a biosensor |